Elevated Reticulocyte Count and G-6-PD Assay Interference
True. An elevated reticulocyte count can interfere with the G-6-PD assay, potentially causing falsely normal results in G-6-PD deficient patients.
Mechanism of Interference
- Reticulocytes contain significantly higher amounts of G-6-PD enzyme than mature erythrocytes 1
- In patients with hemolytic conditions, reticulocytosis can mask underlying G-6-PD deficiency by elevating the overall measured enzyme activity 2
- This interference is particularly problematic in:
- Neonates with physiologic reticulocytosis
- Patients with hemolytic anemia
- Patients recovering from acute blood loss
- Patients responding to treatment for anemia
Clinical Evidence
- According to the American Society of Hematology guidelines, reticulocytosis can significantly impact G-6-PD activity measurements 1
- In pyruvate kinase deficiency studies, researchers have observed that reticulocyte-rich blood can mask enzyme deficiencies, which applies similarly to G-6-PD testing 2
- In G-6-PD deficient patients with high reticulocyte counts, the G-6-PD activity may fall within reference limits despite the underlying deficiency 2
Detection Strategies
To mitigate this interference and improve diagnostic accuracy:
- Compare enzyme ratios: Calculate the ratio of G-6-PD activity to another age-dependent enzyme (similar to PK/HK ratio approach) 2
- Flow cytometric assay: This method has shown better reliability in detecting G-6-PD deficiency in the presence of reticulocytosis compared to spectrophotometric methods 3
- Genetic testing: For definitive diagnosis in cases with suspected interference, molecular analysis for common G-6-PD mutations is recommended 4
Clinical Implications
- Misdiagnosis of G-6-PD deficiency due to reticulocytosis can lead to:
- Inappropriate administration of oxidative drugs
- Unexpected hemolytic crises
- Severe hyperbilirubinemia in neonates 2
- Delayed appropriate management
Recent Research Findings
While the traditional understanding has been that reticulocytosis interferes with G-6-PD assays, some recent studies have challenged this view:
- A 2022 study found that reticulocytosis did not have a statistically significant effect on the detection of G-6-PD deficiency in newborns using both qualitative and quantitative methods 5
- However, this finding contradicts established clinical practice and earlier research, so caution is still warranted 2, 1
Best Practice Recommendations
- When G-6-PD deficiency is suspected but test results are normal or borderline:
- Consider the reticulocyte count when interpreting G-6-PD assay results
- Repeat testing when reticulocyte count normalizes
- Consider molecular testing for definitive diagnosis in critical cases
- Use flow cytometric methods when available for more accurate assessment 3
The interference of reticulocytosis with G-6-PD assay results remains an important clinical consideration that can impact patient management and outcomes, particularly in preventing severe hemolytic episodes.